TREM2 in neurodegenerative diseases

TR Jay, VE von Saucken, GE Landreth - Molecular neurodegeneration, 2017 - Springer
TREM2 variants have been identified as risk factors for Alzheimer's disease (AD) and other
neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively …

Elucidating the role of TREM2 in Alzheimer's disease

JD Ulrich, TK Ulland, M Colonna, DM Holtzman - Neuron, 2017 - cell.com
Alzheimer's disease (AD) is the sixth leading cause of death in the United States and the
most common cause of dementia in the elderly. Genetic factors, such as rare variants in the …

TREM2-ligand interactions in health and disease

DL Kober, TJ Brett - Journal of molecular biology, 2017 - Elsevier
The protein triggering receptor expressed on myeloid cells-2 (TREM2) is an
immunomodulatory receptor with a central role in myeloid cell activation and survival. In …

TREM2 function in Alzheimer's disease and neurodegeneration

JD Ulrich, DM Holtzman - ACS chemical neuroscience, 2016 - ACS Publications
Alzheimer's disease (AD), the most common cause of dementia in the elderly, is a complex
neurodegenerative disease marked by the appearance of amyloid-β (Aβ) plaques and …

Microglia in prion diseases

A Aguzzi, C Zhu - The Journal of clinical investigation, 2017 - jci.org
Prion diseases are a group of progressive and fatal neurodegenerative disorders
characterized by deposition of scrapie prion protein (PrPSc) in the CNS. This deposition is …

RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection

JA Carroll, B Race, K Williams, J Striebel, B Chesebro - Molecular brain, 2020 - Springer
Background Prion diseases and prion-like disorders, including Alzheimer's disease and
Parkinson's disease, are characterized by gliosis and accumulation of misfolded aggregated …

[HTML][HTML] Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion …

N Makarava, JCY Chang, K Molesworth… - Neurobiology of …, 2020 - Elsevier
Chronic neuroinflammation is recognized as a major neuropathological hallmark in a broad
spectrum of neurodegenerative diseases including Alzheimer's, Parkinson's, Frontal …

Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the Hisayama study

T Ohara, J Hata, M Tanaka, T Honda… - Annals of …, 2019 - Wiley Online Library
Objective To investigate the association between serum soluble triggering receptor
expressed on myeloid cells 2 (sTREM2), a soluble type of an innate immune receptor …

Neuroinflammation in prion disease

B Li, M Chen, C Zhu - International Journal of Molecular Sciences, 2021 - mdpi.com
Neuroinflammation, typically manifest as microglial activation and astrogliosis accompanied
by transcriptomic alterations, represents a common hallmark of various neurodegenerative …

[HTML][HTML] Loss of homeostatic microglia signature in prion diseases

Y Wang, K Hartmann, E Thies, B Mohammadi… - Cells, 2022 - mdpi.com
Prion diseases are neurodegenerative diseases that affect humans and animals. They are
always fatal and, to date, no treatment exists. The hallmark of prion disease pathophysiology …